Bladder Cancer | The Current and Future Role of Immune Checkpoint Inhibitors and Other Novel Therapies in Urothelial Bladder Cancer

published 11 months ago by Dr Neil Love

Featuring perspectives from Drs Arjun Balar, Siamak Daneshmand, Ashish M Kamat and Jonathan E Rosenberg on the following topics: Introduction (00:00) Immune checkpoint inhibitors for non-muscle-invasive urothelial bladder cancer (UBC) (4:17) Immune checkpoint inhibitors as neoadjuvant/adjuvant therapy for muscle-invasive UBC (25:42) Immune checkpoint inhibitors in advanced UBC (35:28) Current and future roles of recently FDA-approved novel therapies (51:02) CME information and select publications

more episodes from Research To Practice | Oncology Videos